Schedule XIV – Norway – Pharmaceuticals  Page 5           WT/Let/1268   
SCHEDULE XIV – NORWAY  
         
23 June 2017 
  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 6                  WT/Let/1268 ANNEX I 
List of international non-proprietary names (INNs) t o be added to the list of products receiving duty-f ree treatment 
included in Annex 3 to Annex I to Regulation (EEC) No  2658/87 
 
 
CN code CAS RN Name 
2842 90 80 119175-48-3 fermagate  
2843 90 90 759457-82-4 padeliporfin  
2844 40 30 123748-56-1 iodofiltic acid ( 123 I)  
2904 10 00 21668-77-9 eprodisate  
2906 19 00 199798-84-0 elocalcitol  
2909 30 90 24150-24-1 terameprocol  
2916 19 95 81485-25-8 peretinoin  
2916 39 00 51543-40-9 tarenflurbil  
2918 19 98 174022-42-5 bevirimat  
2919 90 00 258516-89-1 fospropofol  
2920 90 85 163133-43-5 naproxcinod  
2921 19 99 3687-18-1 tramiprosate  
2922 19 85 68392-35-8 afimoxifene  
2922 19 85 753449-67-1 ronacaleret  
2922 29 00 433265-65-7 faxeladol  
2922 50 00 121524-08-1 amibegron  
2922 50 00 329773-35-5 cinaciguat  
2922 50 00 643094-49-9 fasobegron  
2923 10 00 856676-23-8 choline fenofibrate  
2924 29 98 847353-30-4 arbaclofen placarbil  
2924 29 98 194785-19-8 bedoradrine  
2924 29 98 194085-75-1 carisbamate 
2924 29 98 254750-02-2 emricasan  
2924 29 98 355129-15-6 eprotirome  
2924 29 98 402567-16-2 firategrast  
2924 29 98 478296-72-9 gabapentin enacarbil  
2924 29 98 15866-90-7 incyclinide  
2924 29 98 202844-10-8 indantadol  
2924 29 98 96847-55-1 levomilnacipran  
2924 29 98 608137-32-2 lisdexamfetamine  
2924 29 98 652990-07-3 milveterol  
2924 29 98 181816-48-8 ombrabulin  
2924 29 98 289656-45-7 senicapoc  
2925 19 95 19171-19-8 pomalidomide  
2928 00 90 22033-87-0 olesoxime  
2928 00 90 2675-35-6 sivifene  
2928 00 90 816458-31-8 tecovirimat  
2928 00 90 238750-77-1 tosedostat  
2928 00 90  149647-78-9 vorinostat  
2929 90 00 31645-39-3 palifosfamide  
2930 90 99 608141-41-9 apremilast  
2930 90 99 216167-92-9 camobucol  
2930 90 99 211513-37-0 dalcetrapib  
2930 90 99 69819-86-9 darinaparsin  
2930 90 99 488832-69-5 elesclomol  
2930 90 99 216167-95-2 elsibucol  
2930 90 99 168682-53-9 ezatiostat  
2930 90 99 58569-55-4 metenkefalin  
2930 90 99 887148-69-8 monepantel  
2930 90 99 603139-19-1 odanacatib  
2930 90 99 162520-00-5 salirasib  
2930 90 99 216167-82-7 succinobucol  
2930 90 99 125961-82-2 tipelukast  
2931 00 99 125973-56-0 amsilarotene  
2932 19 00 253128-41-5 eribulin  
2932 19 00 186953-56-0 pafuramidine  
2932 29 85 195883-06-8 omtriptolide  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 7                  WT/Let/1268 CN code CAS RN Name 
2932 99 00 664338-39-0 arterolane  
2932 99 00 183133-96-2 cabazitaxel  
2932 99 00 401925-43-7 celivarone  
2932 99 00 461432-26-8 dapagliflozin  
2932 99 00 118457-15-1 dexnebivolol  
2932 99 00 156294-36-9 larotaxel  
2932 99 00 118457-16-2 levonebivolol  
2932 99 00 83461-56-7 mifamurtide  
2932 99 00 117570-53-3 vadimezan  
2933 19 90 496775-61-2 eltrombopag  
2933 19 90 206884-98-2 niraxostat  
2933 19 90 410528-02-8 palovarotene  
2933 19 90 376592-42-6 totrombopag  
2933 29 90 183659-72-5 catramilast  
2933 29 90 944263-65-4 demiditraz  
2933 29 90 867153-61-5 dulanermin  
2933 29 90 320367-13-3 lixisenatide  
2933 29 90 698389-00-3 rolipoltide  
2933 29 90 697766-75-9 velafermin  
2933 39 99 147084-10-4 alcaftadine  
2933 39 99 54-96-6 amifampridine  
2933 39 99 249921-19-5 anamorelin  
2933 39 99 319460-85-0 axitinib  
2933 39 99 208110-64-9 befiradol  
2933 39 99 330942-05-7 betrixaban  
2933 39 99 201034-75-5 daporinad  
2933 39 99 209783-80-2 entinostat  
2933 39 99 412950-27-7 goxalapladib  
2933 39 99 218791-21-0 imisopasem manganese  
2933 39 99 103129-82-4 levamlodipine  
2933 39 99 154357-42-3 levonadifloxacin  
2933 39 99 108147-54-2 migalastat  
2933 39 99 453562-69-1 motesanib  
2933 39 99 139145-27-0 parogrelil  
2933 39 99 459856-18-9 pexacerfont  
2933 39 99 706779-91-1 pimavanserin  
2933 39 99 362665-56-3 pitolisant 
2933 39 99 861151-12-4 rosonabant  
2933 39 99 701977-09-5 taranabant  
2933 39 99 189950-11-6 tropantiol  
2933 39 99 793655-64-8 vapitadine  
2933 39 99 139290-65-6 volinaserin  
2933 49 90 141388-76-3 besifloxacin  
2933 49 90 697761-98-1 elvitegravir  
2933 49 90 185055-67-8 ferroquine  
2933 49 90 445041-75-8 intiquinatine  
2933 49 90 378746-64-6 nemonoxacin  
 2933 49 90 245765-41-7 ozenoxacin  
2933 49 90 412950-08-4 rilapladib  
2933 49 90 871224-64-5 almorexant  
2933 49 90 863029-99-6 balamapimod  
2933 49 90 698387-09-6 neratinib  
2933 49 90 154652-83-2 tezampanel  
2933 49 90 128253-31-6 veliflapon  
2933 59 95 791828-58-5 aderbasib  
2933 59 95 840486-93-3 adipiplon  
2933 59 95 850649-61-5 alogliptin  
2933 59 95 859212-16-1 bafetinib 
2933 59 95 380843-75-4 bosutinib  
2933 59 95 839712-12-8 cariprazine  
2933 59 95 414910-27-3 casopitant  
2933 59 95 288383-20-0 cediranib  
2933 59 95 849550-05-6 cevipabulin  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 8                  WT/Let/1268 CN code CAS RN Name 
2933 59 95 827318-97-8 danusertib  
2933 59 95 356057-34-6 darapladib  
2933 59 95 501000-36-8 dutacatib  
2933 59 95 247257-48-3 fimasartan  
2933 59 95 3432-99-3 folitixorin  
2933 59 95 668270-12-0 linagliptin  
2933 59 95 441798-33-0 macitentan  
2933 59 95 641571-10-0 nilotinib  
2933 59 95 763113-22-0 olaparib  
2933 59 95 686344-29-6 otenabant  
2933 59 95 625115-55-1 riociguat  
2933 59 95 486460-32-6 sitagliptin  
2933 59 95 425637-18-9 sotrastaurin  
2933 59 95 309913-83-5 talmapimod  
2933 59 95 113857-87-7 talotrexin  
2933 59 95 274693-27-5 ticagrelor  
2933 59 95 306296-47-9 vicriviroc  
2933 69 80 775351-65-0 imeglimin  
2933 79 00 461443-59-4 aplaviroc  
2933 79 00 189691-06-3 bremelanotide  
2933 79 00 813452-18-5 carmegliptin  
2933 79 00 405169-16-6 dovitinib  
2933 79 00 536748-46-6 eribaxaban  
2933 79 00 473289-62-2 ilepatril  
2933 79 00 180694-97-7 mimopezil  
2933 79 00 579475-18-6 orvepitant  
2933 79 00 449811-01-2 pamapimod  
2933 79 00 248282-01-1 paquinimod  
2933 79 00 380917-97-5 perampanel  
2933 79 00 552292-08-7 rolapitant  
2933 79 00 425386-60-3 semagacestat  
2933 79 00 515814-01-4 voclosporin  
2933 99 80 481629-87-2 aleplasinin  
2933 99 80 394730-60-0 boceprevir  
2933 99 80 649735-63-7 brivanib alaninate  
2933 99 80 483369-58-0 denagliptin  
2933 99 80 284019-34-7 denibulin  
2933 99 80 481631-45-2 diaplasinin  
2933 99 80 272105-42-7 disitertide  
2933 99 80 227318-71-0 epetirimod  
2933 99 80 259793-96-9 favipiravir  
2933 99 80 871576-03-3 flovagatran  
2933 99 80 229305-39-9 golotimod  
2933 99 80 258818-34-7 larazotide  
2933 99 80 571170-77-9 laropiprant  
2933 99 80 616202-92-7 lorcaserin  
2933 99 80 868771-57-7 melogliptin  
2933 99 80 803712-67-6 obatoclax  
2933 99 80 404950-80-7 panobinostat  
2933 99 80 625114-41-2 piragliatin  
2933 99 80 74847-35-1 pyronaridine  
2933 99 80 872178-65-9 rabeximod  
2933 99 80 355151-12-1 rotigaptide  
2933 99 80 497221-38-2 rusalatide  
2933 99 80 187602-11-5 sofigatran  
2933 99 80 227318-75-4 sotirimod  
2933 99 80 402957-28-2 telaprevir  
2933 99 80 848084-83-3 tigapotide  
2933 99 80 393105-53-8 tiplasinin  
2933 99 80 620948-93-8 vabicaserin  
2933 99 80 794466-70-9 vernakalant  
2934 10 00 544417-40-5 capadenoson 
2934 10 00 302962-49-8 dasatinib  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 9                  WT/Let/1268 CN code CAS RN Name 
2934 10 00 223132-37-4 inolitazone  
2934 10 00 241479-67-4 isavuconazole  
2934 10 00 338990-84-4 isavuconazonium chloride 
2934 10 00 607723-33-1 lobeglitazone  
2934 10 00 280782-97-0 managlinat dialanetil  
2934 10 00 790299-79-5 masitinib  
2934 10 00 223673-61-8 mirabegron  
2934 10 00 501948-05-6 rosabulin  
2934 10 00 447406-78-2 sodelglitazar  
2934 10 00 760937-92-6 teneligliptin  
2934 20 80 848344-36-5 bentamapimod  
2934 20 80 870093-23-5 talarozole  
2934 99 90 320345-99-1 aclidinium bromide  
2934 99 90 222551-17-9 adoprazine  
2934 99 90 207623-20-9 agatolimod  
2934 99 90 475479-34-6 aleglitazar  
2934 99 90 870524-46-2 amolimogene bepiplasmid  
2934 99 90 875446-37-0 anacetrapib  
2934 99 90 250386-15-3 apadenoson  
2934 99 90 541550-19-0 apilimod  
2934 99 90 160707-69-7 apricitabine  
2934 99 90 147403-03-0 azilsartan  
2934 99 90 863031-21-4 azilsartan medoxomil  
2934 99 90 757942-43-1 bederocin  
2934 99 90 627861-07-8 beperminogene perplasmid  
2934 99 90 959961-96-7 bevasiranib  
2934 99 90 769901-96-4 capeserod  
2934 99 90 868540-17-4 carfilzomib  
2934 99 90 872847-66-0 cenersen  
2934 99 90 80295-38-1 conestat alfa  
2934 99 90 903916-27-8 custirsen  
2934 99 90 187865-22-1 derquantel  
2934 99 90 134379-77-4 dexelvucitabine  
2934 99 90 247046-52-2 dilopetine  
2934 99 90 480449-70-5 edoxaban  
2934 99 90 188181-42-2 elacytarabine  
2934 99 90 98819-76-2 esreboxetine  
2934 99 90 763903-67-9 fosalvudine tidoxil  
2934 99 90 172673-20-0 fosaprepitant  
2934 99 90 522664-63-7 ibodutant  
2934 99 90 405159-59-3 idrabiotaparinux sodium 
2934 99 90 188116-07-6 imepitoin  
2934 99 90 335619-18-6 inakalant  
2934 99 90 1391-36-2 lancovutide  
2934 99 90 189059-71-0 lapaquistat  
2934 99 90 327026-93-7 lensiprazine  
2934 99 90 170632-47-0 lificiguat  
2934 99 90 852313-25-8 litenimod  
2934 99 90 1000120-98-8 mipomersen  
2934 99 90 62253-63-8 nepidermin  
2934 99 90 26833-87-4 omacetaxine mepesuccinate 
2934 99 90 269718-84-5 pardoprunox  
2934 99 90 219923-85-0 pramiconazole  
2934 99 90 377727-87-2 preladenant  
2934 99 90 524684-52-4 prinaberel  
2934 99 90 865311-47-3 quarfloxin  
2934 99 90 869884-78-6 radezolid  
2934 99 90 496054-87-6 radiprodil  
2934 99 90 518048-05-0 raltegravir  
2934 99 90 787548-03-2 regrelor  
2934 99 90 820957-38-8 retosiban 
2934 99 90 572924-54-0 ridaforolimus 
2934 99 90 128517-07-7 romidepsin  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 10                  WT/Let/1268 CN code CAS RN Name 
2934 99 90 93265-81-7 ropidoxuridine  
2934 99 90 151823-14-2 sapacitabine  
2934 99 90 379231-04-6 saracatinib  
2934 99 90 791635-59-1 simotaxel  
2934 99 90 119567-79-2 taribavirin  
2934 99 90 332012-40-5 telatinib  
2934 99 90 925681-61-4 trabedersen  
2934 99 90 189003-92-7 trelanserin  
2934 99 90 296251-72-4 velimogene aliplasmid 
2934 99 90 904302-98-3 viquidacin  
2934 99 90 872525-61-6 votucalis  
2934 99 90 221877-54-9 zotarolimus  
2935 00 90 197904-84-0 apricoxib  
2935 00 90 769169-27-9 begacestat  
2935 00 90 414864-00-9 belinostat  
2935 00 90 313682-08-5 brecanavir  
2935 00 90 839673-52-8 cevoglitazar  
2935 00 90 358970-97-5 drinabant  
2935 00 90 865200-20-0 giripladib  
2935 00 90 464213-10-3 ibipinabant  
2935 00 90 173424-77-6 laromustine  
2935 00 90 398507-55-6 lodenafil carbonate  
2935 00 90 136564-68-6 masilukast  
2935 00 90 170569-88-7 mavacoxib  
2935 00 90 862189-95-5 mirodenafil  
2935 00 90 439687-69-1 nelivaptan  
2935 00 90 691852-58-1 nesbuvir  
2935 00 90 778576-62-8 oglemilast  
2935 00 90 444731-52-6 pazopanib  
2935 00 90 362505-84-8 relacatib  
2935 00 90 243984-11-4 resatorvid  
2935 00 90 519055-62-0 tasisulam  
2935 00 90 186497-07-4 zibotentan  
2936 29 00 104121-92-8 eldecalcitol 
2936 29 00 31690-09-2 levomefolic acid  
2937 19 00 782500-75-8 albiglutide  
2937 19 00 348119-84-6 obinepitide  
2937 19 00 295350-45-7 ozarelix  
2937 19 00 275371-94-3 taspoglutide  
2937 19 00 218949-48-5 tesamorelin  
2937 19 00 22006-64-0 tridecactide  
2937 22 00 132245-57-9 dexamethasone cipecilate 
2937 22 00 397864-44-7 fluticasone furoate 
2937 29 00 211254-73-8 lonaprisan 
2937 50 00 333963-42-1 cobiprostone  
2937 50 00 172740-14-6 posaraprost  
2937 90 00 834153-87-6 elagolix  
2937 90 00  609799-22-6 tasimelteon  
2937 90 00 342577-38-2 velneperit  
2939 19 00 73232-52-7 methylnaltrexone bromide 
2939 59 00 136199-02-5 rolofylline  
2939 99 00 850607-58-8 darotropium bromide  
2939 99 00 187852-63-7 delimotecan 
2940 00 00 9007-72-1 ferric carboxymaltose 
2940 00 00 442201-24-3 remogliflozin etabonate 
2940 00 00  408504-26-7 sergliflozin etabonate 
2941 90 00 467214-20-6 alvespimycin 
2941 90 00 677017-23-1 berubicin 
2941 90 00 229016-73-3 ceftaroline fosamil  
2941 90 00 318498-76-9 flopristin  
2941 90 00  145435-72-9 gamithromycin  
2941 90 00 325965-23-9 linopristin  
2941 90 00 857402-23-4 retaspimycin  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 11                  WT/Let/1268 CN code CAS RN Name 
2941 90 00 305841-29-6 sagopilone  
2941 90 00 75747-14-7 tanespimycin 
2941 90 00 328898-40-4 tildipirosin  
2941 90 00  222400-20-6 tomopenem  
2941 90 00 63409-12-1 tylvalosin  
3001 90 91 9041-08-1 semuloparin sodium  
3002 10 91 792921-10-9 abagovomab  
3002 10 91 910649-32-0 anrukinzumab  
3002 10 91 648904-28-3 bavituximab  
3002 10 91 402710-27-4  
(light chain) 
402710-25-2  
(heavy chain) canakinumab  
3002 10 99 945228-49-9 citatuzumab bogatox  
3002 10 91 880486-59-9 dacetuzumab  
3002 10 91 615258-40-7 denosumab  
3002 10 91 762260-74-2 efungumab  
3002 10 91 89957-37-9 gantenerumab  
3002 10 91 680188-33-4 ibalizumab  
3002 10 91 477202-00-9 ipilimumab  
3002 10 91 640735-09-7 iratumumab  
3002 10 91 845816-02-6 lexatumumab  
3002 10 91 903512-50-5 lucatumumab  
3002 10 91 899796-83-9 milatuzumab  
3002 10 91 677010-34-3 motavizumab  
3002 10 91 676258-98-3 naptumomab estafenatox 
3002 10 91 828933-51-3 nimotuzumab  
3002 10 91 949142-50-1 obinutuzumab 
3002 10 91 637334-45-3 ocrelizumab  
3002 10 91 881191-44-2 otelixizumab  
3002 10 91 372075-37-1 sontuzumab  
3002 10 91 705287-60-1 stamulumab  
3002 10 91 339086-80-5 tadocizumab  
3002 10 91 592557-43-2  
(light chain) 
592557-41-0 
(heavy chain) tenatumomab 
3002 10 91 876387-05-2 teplizumab  
3002 10 91 918127-53-4 tigatuzumab  
3002 10 91 745013-59-6 tremelimumab 
3002 10 91 339986-90-2 tucotuzumab celmoleukin  
3002 10 91 728917-18-8 veltuzumab  
3002 10 91  896731-82-1 conatumumab  
3002 10 91  892553-42-3 etaracizumab  
3002 10 91  944548-38-3 foravirumab  
3002 10 91  944548-37-2 rafivirumab  
3002 10 91  880266-57-9 tanezumab  
3002 10 91  815610-63-0 ustekinumab  
3002 10 95 862111-32-8 aflibercept  
3002 10 95 845264-92-8 atacicept  
3002 10 95 909110-25-4 baminercept  
3002 10 95 9001-27-8 beroctocog alfa  
3002 10 95 879555-13-2 epoetin kappa  
3002 10 95 762263-14-9 epoetin theta  
3002 10 95 501081-76-1 rilonacept  
3002 10 95 267639-76-9 romiplostim  
3002 10 95 869858-13-9 thrombin alfa  
3002 10 95 897936-89-9 vatreptacog alfa (activated)  
3002 10 95  472960-22-8 albinterferon alfa-2b  
3002 10 95  869881-54-9 briobacept  
3002 10 95  606138-08-3 catridecacog  
3002 10 95  716840-32-3 denenicokin  
3002 10 95  931101-84-7 troplasminogen alfa  Schedule XIV – Norway – Pharmaceuticals – Annex I  Page 12                  WT/Let/1268 CN code CAS RN Name 
3002 10 99 934216-54-3 alacizumab pegol  
3002 20 00 181477-43-0 disomotide  
3002 20 00 181477-91-8 ovemotide  
3002 20 00 915019-08-8 tertomotide  
3002 20 00 295371-00-5 verpasep caltespen 
3002 90 90 473553-86-5 alferminogene tadenovec  
3002 90 90 929881-05-0 alipogene tiparvovec  
3002 90 90 600735-73-7 contusugene ladenovec 
3002 90 90 851199-59-2 linaclotide 
3002 90 90 898830-54-1 sitimagene ceradenovec 
3002 90 90 721946-42-5 transferrin aldifitox 
3507 90 90 9026-00-0 bucelipase alfa  
3507 90 90 885051-90-1 pegloticase  
3507 90 90 884604-91-5 velaglucerase alfa  
3911 90 99 892497-01-7 azoximer bromide 
 
 Schedule XIV – Norway – Pharmaceuticals – Annex II  Page 13                  WT/Let/1268 ANNEX II 
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Annex I to Regulation ( EEC) No 
2658/87, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition 
that they are classifiable in the same six-digit HS  subheading as the corresponding INN 
 
The references to "International Nonproprietary Nam es (INN) for pharmaceutical substances, Names for r adicals & groups, 
comprehensive list 2004" are replaced by "Internati onal Nonproprietary Names (INN) for pharmaceutical substances, Names 
for radicals, groups & others, comprehensive list 2 007". 
 
The following prefixes or suffixes are added: 
 
 
Preferred prefix 
or suffix Synonym Systematic name  
when different 
alanetil (INNRG)   [(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN) 
alaninate (INNRG)  L-alaninate (INNCN) 
alapivoxil (INNRG)  L-alanyl, [(2,2-dimethylpropanoy l)oxy]methyl (INNCN) 
aldifitox (INNRG)  (4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-
dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl an d 
forming an N-benzoyl derivative of a primary amine 
group of diphtheria [550-L-phenylalanine]toxin from  
Corynebacterium diphtheriae -(26-560)-peptide (INNCN) 
besudotox (INNRG)  L-lysyl-L-alanyl-L-serylglycylgly cine (linker) fusion 
protein with des-(365-380)-
[Asn 364 ,Val 407 ,Ser 515 ,Gln 590 ,Gln 606 ,Arg 613 ]exotoxin A 
(Pseudomonas aeruginosa )-(251-613)-peptide (toxin with 
region IA and first 16 residues of region IB deleted ) 
(INNCN) 
ceribate (INNRG)  rac-2,3-dihydroxypropyl carbonate (ester) (INNCN) 
cipecilate (INNRG)  cyclohexanecarboxylate (ester),  cyclopropanecarboxylate 
(ester) (INNCN) 
dalanated (INNRG)  des-B30-alanine (INNCN) 
enacarbil (INNRG)  {rac-1-[(2-methylpropanoyl)oxy]et hoxy}carbonyl 
(INNCN) 
estafenatox (INNRG)  glycylglycyl-L-proline (linker ) fusion protein with 
enterotoxin type A ( Staphylococcus aureus )-(1-33)-
peptidyl-L-
seryl[Ser 36 ,Ser 37 ,Glu 38 ,Lys 39 ,Ala 41 ,Thr 46 ,Thr 71 ,Ala 72 ,Ser 75 ,
Glu 76 ,Glu 78 ,Ser 80 ,Ser 81 ,Thr 214 ,Ser 217 ,Thr 219 ,Ser 220 ,Ser 222 ,S
er 224 ]enterotoxin type E ( Staphylococcus aureus )-(32-
230)-peptide (synthetic superantigen SEA/E-120) 
(INNCN) 
etexilate (INNRG)  ethyl, (hexyloxy)carbonyl 
fosamil (INNRG)  phosphono (INNCN) 
glucuronide (INNRG)  β-D-glucopyranosiduronic acid [oside] (INNCN) 
medocaril (INNRG)  [(5-methyl-2-oxo-1,3-dioxol-4-yl) methoxy]carbonyl 
(INNCN) 
paptox (INNRG)  protein PAP ( Phytolacca americana  antiviral) (INNCN) 
placarbil (INNRG)  (R)-2-methyl-1-[(2-
methylpropanoyl)oxy]propoxy}carbonyl) (INNCN) 
 Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 14                  WT/Let/1268 ANNEX III 
List of pharmaceutical intermediates, i.e. compounds  used for the manufacture of finished pharmaceutica l products, 
to be added to the list of products receiving duty- free treatment included in Annex 6 to Annex I to Re gulation (EEC) 
No 2658/87 
 
ID CN code CAS RN Name 
95 2843 29 00 22199-08-2 [4-amino-N-(pyrimidin-2(1H )-ylidene-κN1)benzenesulfonamidato-
κO]silver 
428 2905 39 95 281214-27-5 (2R,3R)-2,3-dimethylbutane -1,4-diyl bis(4-methylbenzenesulfonate) 
76 2905 59 98 441002-17-1 4-chlorobutyl 2-nitrobenz enesulfonate 
538 2909 30 90 92878-95-0 2-(3-chloropropoxy)-1-met hoxy-4-nitrobenzene 
168 2909 30  503070-57-3 2-({2-[(6-bromohexyl)oxy]e thoxy}methyl)-1,3-dichlorobenzene 
386 2909 30  461432-23-5 4-(5-bromo-2-chlorobenzyl) phenyl ethyl ether 
51 2909 49 80 185954-75-0 (3R)-3-methoxydecan-1-ol 
167 2909 49 80 85309-91-7 2-[(2,6-dichlorobenzyl)ox y]ethanol 
64 2909 49 80 160969-03-9 2-[2-(2,2,2-trifluoroetho xy)phenoxy]ethyl methanesulfonate 
98 2909 50 00 167145-13-3 2-[2-(3-methoxyphenyl)eth yl]phenol 
377 2910 20 00 15448-47-2 (2R)-2-methyloxirane 
177 2910 90 00 62600-71-9 (2R)-2-(3-chlorophenyl)oxi rane 
184 2910 90 00 702687-42-1 (2R)-2-[(5-bromo-2,3-difl uorophenoxy)methyl]oxirane 
88 2910 90 00 683276-64-4 [(2R)-2-methyloxiran-2-yl] methyl 4-nitrobenzenesulfonate 
191 2913 00 00 90035-34-0 4'-(trifluoromethyl)biphe nyl-4-carbaldehyde 
38 2914 40 90 17752-16-8 (3 β)-3-hydroxycholest-5-en-24-one 
244 2914 50 00 974-23-2 (3 β,16 α)-3-hydroxy-16,17-epoxypregn-5-en-20-one 
586 2914 70 00 13054-81-4 4-chloro-heptane-3,5-dion e 
236 2914 70 00 10226-30-9 6-chlorohexan-2-one 
122 2915 60 90 53064-79-2 iodomethyl pivalate 
426 2915 90 00 22328-90-1 (3R)-3-methylhexanoic acid  
266 2915 90 00 1069-66-5 sodium 2-propylpentanoate 
19 2916 20 00 211515-46-7 1-(2-ethylbutyl)cyclohexa necarbonyl chloride 
32 2916 20 00 381209-09-2 1-(2-ethylbutyl)cyclohexa necarboxylic acid 
37 2916 20 00 7077-05-6 trans-4-(propan-2-yl)cycloh exanecarboxylic acid 
531 2916 39 00 21900-39-0 5-fluoro-2-methylbenzoyl chloride 
250 2916 39 00 17625-03-5 sodium hydrogen 3-sulfona tobenzoate 
561 2917 19 90 76-72-2 diethyl ethyl(pentan-2-yl)pr opanedioate 
193 2918 29 00 376592-58-4 5'-chloro-2'-hydroxy-3'- nitrobiphenyl-3-carboxylic acid 
369 2918 99 90 709031-28-7 (3-hydroxytricyclo[3.3.1 .1(3,7)]dec-1-yl)(oxo)acetic acid 
552 2918 99 90 35480-52-5 2,5-bis(2,2,2-trifluoroet hoxy)benzoic acid 
559 2918 99 90 4651-67-6 (3 α,5 β)-3-hydroxy-7-oxocholan-24-oic acid 
264 2918 99 90 52179-28-9 ethyl 2-[4-(2,2-dichloroc yclopropyl)phenoxy]-2-methylpropanoate 
143 2918 99 90 530141-60-7 methyl 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]ca rbonyl}-2-
hydroxyphenyl)propanoate 
114 2920 90 10 91526-18-0 4-(hydroxymethyl)-5-methy l-1,3-dioxol-2-one 
161 2921 49 00 334477-60-0 (1R)-1-[3,5-bis(trifluoro methyl)phenyl]-N-methylethanamine 
287 2921 49 00 376608-71-8 (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R) -
hydroxy(phenyl)ethanoate 
342 2921 49 00 1034457-07-2 2-(2,3-dihydro-1H-inden -2-yl)propan-2-amine hydrochloride 
27 2921 49 00 945717-05-5 2-(4-chloro-3-ethylphenyl )ethanamine hydrochloride 
221 2921 49 00 89-97-4 2-chlorobenzylamine 
26 2921 49 00 945717-43-1 N-(4-tert-butylbenzyl)-2- (4-chloro-3-ethylphenyl)ethanamine 
518 2921 51 90 150812-21-8 N4-[(4-fluorophenyl)meth yl]-2-nitro-1,4-benzenediamine 
343 2922 19 80 1035455-90-3 (2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihy dro-1H-inden-
2-yl)-2-methylpropan-2- 
yl]amino}propan-2-ol hydrochloride 
397 2922 19 80 0-00-0 [2-(chloromethyl)-4-(dibenzyl amino)phenyl]methanol hydrochloride 
248 2922 19 80 133-51-7 antimonic acid -- 1-deoxy-1 -(methylamino)-D-glucitol (1:1) 
344 2922 19 80 1035455-87-8 ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2 -yl)-2-
methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-
difluorophenyl)prop-2-enoate hydrochloride 
185 2922 19 80 702686-97-3 ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)- 2-methylpropan-
2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl )propanoate 
hydrochloride 
36 2922 29 00 20059-73-8 2-[4-(aminomethyl)phenoxy] -N,N-dimethylethanamine 
536 2922 49 85 848133-35-7 (2E)-4-(dimethylamino)bu t-2-enoic acid hydrochloride Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 15                  WT/Let/1268 ID CN code CAS RN Name 
425 2922 49 85 610300-07-7 (3S,5R)-3-amino-5-methylo ctanoic acid 
424 2922 49 85 610300-00-0 (3S,5R)-3-amino-5-methylo ctanoic acid hydrochloride 
433 2922 49 85 143785-86-8 4-(1-aminocyclopropyl)-2 ,3,5-trifluorobenzoic acid 
398 2922 49 85 848949-85-9 4-fluoro-L-leucine -- et hyl hydrogen sulfate (1:1) 
475 2922 49 85 39068-93-4 methyl 2-(dimethylamino)- 2-phenylbutanoate 
174 2922 49 85 168619-25-8 methyl 3'-aminobiphenyl- 3-carboxylate 
565 2922 49 85 82834-12-6 N-[(2S)-1-ethoxy-1-oxopen tan-2-yl]-L-alanine 
474 2922 49 85 94133-84-3 sodium 2-amino-2-phenylbu tanoate 
171 2922 50 00 503070-58-4 triphenylacetic acid -- 4-{(1R)-2-[(6-{2-[(2,6-
dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyeth yl}-2-
(hydroxymethyl)phenol (1:1) 
149 2924 19 00 62009-47-6 2-aminomalonamide 
175 2924 19 00 7355-58-0 N-(2-chloroethyl)acetamide  
367 2924 29 98 361442-00-4 {2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3 .3.1.1(3,7)]dec-1-
yl}acetic acid 
521 2924 29 98 266993-72-0 2,3-diaminobenzamide dih ydrochloride 
532 2924 29 98 168080-49-7 2-chloro-4-{[(5-fluoro-2 -methylphenyl)carbonyl]amino}benzoic acid 
81 2924 29 98 317374-08-6 2-methyl-4-{[(2-methylphe nyl)carbonyl]amino}benzoic acid 
125 2924 29 98 143785-84-6 4-(1-carbamoylcyclopropy l)-2,3,5-trifluorobenzoic acid 
434 2924 29 98 143785-87-9 4-[1-(acetylamino)cyclop ropyl]-2,3,5-trifluorobenzoic acid 
80 2924 29 98 108166-22-9 4-{[(2-methylphenyl)carbo nyl]amino}benzoic acid 
519 2924 29 98 150812-23-0 ethyl {4-[(4-fluorobenzy l)amino]-2-nitrophenyl}carbamate 
237 2924 29 98 22316-45-6 ethyl 3-[(5-chloro-2-nitr ophenyl)(phenyl)amino]-3-oxopropanoate 
3 2924 29 98 316173-29-2 methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4 -[(tert-
butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxyl ate 
378 2924 29 98 1142-20-7 N-benzyloxycarbonyl-L-alan ine 
102 2924 29 98 84996-93-0 N-cyclohexyl-5-hydroxypen tanamide 
270 2924 29 98 579494-66-9 propyl {4-[2-(diethylami no)-2-oxoethoxy]-3-ethoxyphenyl}acetate 
533 2925 19 95 265136-65-0 ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoind ol-2-
yl)ethoxy]but-2-enoate 
33 2926 90 95 855425-38-6 1-(2-ethylbutyl)cyclohexa necarbonitrile 
537 2926 90 95 846023-24-3 2-cyano-N-(2,4-dichloro- 5-methoxyphenyl)acetamide 
417 2926 90 95 591769-05-0 3-cyclopentylprop-2-enen itrile 
50 2926 90 95 20099-89-2 4-(bromoacetyl)benzonitril e 
54 2926 90 95 474554-45-5 4,5-diethoxy-3-fluorobenz ene-1,2-dicarbonitrile 
587 2926 90 95 79370-78-8 5-hydroxybenzene-1,3-dica rbonitrile 
118 2926 90 95 139481-28-0 methyl 2-{[(2'-cyanobiph enyl-4-yl)methyl]amino}-3-nitrobenzoate 
182 2928 00 90 860035-10-5 1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)eth yl 2-
methylpropanoate 
403 2928 00 90 910656-45-0 2-hydroxy-2-(trifluorome thyl)butanehydrazide 
104 2928 00 90 95759-10-7 4-chloro-2-[(2-methoxy-2- oxoethoxy)imino]-3-oxobutanoic acid 
383 2928 00 90 473927-63-8 ethyl (2Z)-chloro[2-(4-m ethoxyphenyl)hydrazinylidene]ethanoate 
144 2928 00 90 158671-29-5 N,2-dihydroxy-4-methylbe nzamide 
106 2928 00 90 84080-68-2 tert-butyl (2Z)-2-[(2-met hoxy-2-oxoethoxy)imino]-3-oxobutanoate 
105 2928 00 90 268544-50-9 tert-butyl-2-[(2-methoxy -2-oxoethoxy)imino]-3-oxobutanoate 
101 2930 90 85 13459-62-6 {2-[(4-chlorophenyl)sulfa nyl]phenyl}acetic acid 
20 2930 90 85 211513-21-2 1-(2-ethylbutyl)-N-(2-sul fanylphenyl)cyclohexanecarboxamide 
181 2930 90 85 860035-07-0 1-{[(methylsulfanyl)carb onyl]oxy}ethyl 2-methylpropanoate 
396 2930 90 85 893407-18-6 2,2,2-trifluoro-1-[4'-(m ethylsulfonyl)biphenyl-4-yl]ethanone 
86 2930 90 85 60759-00-4 3,4-diethoxybenzenecarboth ioamide 
180 2930 90 85 21048-05-5 N-methylbenzenecarbothioh ydrazide 
47 2931 00 95 13682-94-5 (2-bromoethenyl)(trimethyl )silane 
46 2931 00 95 914922-89-7 (2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-m ethoxy-N,2-
dimethyl-7-oxoheptanamide 
44 2931 00 95 914922-88-6 (2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy- N,2-
dimethyloct-7-enamide 
45 2931 00 95 871355-80-5 (4R)-2-bromo-7-{[tert-butyl(diphenyl)silyl]oxy}hept- 1-en-4-yl 4-
methylbenzenesulfonate 
192 2931 00 95 89694-48-4 (5-chloro-2-methoxyphenyl )boronic acid 
359 2931 00 95 701278-08-2 [(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypro pan-2-
yl)oxy]methyl}cyclopent-2-en-1-yl]methanol 
360 2931 00 95 701278-09-3 {(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)si lyl]cyclopent-
1-en-1-yl}methanol Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 16                  WT/Let/1268 ID CN code CAS RN Name 
318 2931 00 95 796967-18-5 1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetrameth yl-1,3,2-
dioxaborolan-2-yl)phenyl]urea 
52 2931 00 95 172732-52-4 2-(1,3,2-dioxaborinan-2-y l)benzonitrile 
48 2931 00 95 185411-12-5 methyl 3-(trimethylsilyl) pent-4-enoate 
43 2932 19 00 253128-10-8 (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dim ethyl)silyl]-
2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypr opyl)-3-
methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O -methyl-4-
methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D- altro-tridecitol 
571 2932 19 00 441045-17-6 (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S ,33R,3 
5R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy -14-methyl-
8,15-bis(methylene)-2,19,30,34,37,39,40,41-
octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018 ,22.029,36.031,3 
5]hentetracontan-24-one methanesulfonate  
35 2932 29 85 916069-80-2 (4S)-4-(fluoromethyl)dihy drofuran-2(3H)-one 
554 2932 29 85 63106-93-4 1-phenyl-3-oxabicyclo[3.1 .0]hexan-2-one 
140 2932 29 85 7734-80-7 2-oxo-2H-chromene-6-carbox ylic acid 
399 2932 29 85 0-00-0 4-(4-fluorophenyl)-7-(isothio cyanatomethyl)-2H-chromen-2-one 
142 2932 29 85 947408-91-5 6-[(2,4-dihydroxyphenyl) carbonyl]-2H-chromen-2-one 
141 2932 29 85 947408-90-4 6-[(2,4-dimethoxyphenyl) carbonyl]-2H-chromen-2-one 
165 2932 99 00 452342-08-4 (1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodio xin-6-
yl)ethanol 
206 2932 99 00 99541-23-8 (1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-
bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]d ioxin-6-
yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate 
389 2932 99 00 461432-25-7 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro -3-(4-
ethoxybenzyl)phenyl]-D-glucitol 
116 2932 99 00 196597-79-2 (2E)-1,2,6,7-tetrahydro- 8H-indeno[5,4-b]furan-8-ylideneethanenitrile 
550 2932 99 00 3308-94-9 2-(3-chloropropyl)-2-(4-fl uorophenyl)-1,3-dioxolane 
568 2932 99 00 274693-53-7 [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3a H-
cyclopenta[d][1,3]dioxol-4-yl]carbamate 
61 2932 99 00 185954-98-7 [6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-met oxydecyl)-6-
methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphon o-β-D-
glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]- α-D-glucopyranose 1-
(dihydrogen phosphate) tetrasodium salt 
203 2932 99 00 136172-58-2 1,6-di-O-acetyl-2-azido- 3,4-di-O-benzyl-2-deoxy-D-glucopyranose 
115 2932 99 00 196597-80-5 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8- yl]ethanamine 
hydrochloride 
354 2932 99 00 666860-59-9 2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen- 1-yl)-1,3-
dioxan-2-yl]propyl}carbamate 
576 2932 99 00 117661-72-0 5-(chloromethyl)-6-methy l-1,3-benzodioxole 
405 2932 99 00 959624-24-9 6-(hydroxymethyl)-4-phen yl-3,4-dihydro-2H-chromen-2-ol 
388 2932 99 00 960404-59-5 but-2-yne-1,4-diol -- methyl 1-C-[4-chloro-3-(4-etho xybenzyl)phenyl]-
α-D-glucopyranoside (1:1) 
13 2932 99 00 15826-37-6 disodium 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)] bis(4-oxo-4H-
chromene-2-carboxylate) 
28 2932 99 00 204254-84-2 ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy ]-3a,6,7,7a-
tetrahydro-1,3-benzodioxole-5-carboxylate 
205 2932 99 00 99541-26-1 methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acety loxy)-4-azido-
6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(ben zyloxy)-3-
hydroxytetrahydro-2H-pyran-2-carboxylate 
204 2932 99 00 114869-97-5 methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-meth yl-α-L-
idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbony l]amino}-2-
deoxy-α-D-glucopyranoside 
478 2933 19 90 1035677-60-1 (4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihyd ro-1H-pyrazole-
1-carboximidamide 2,3-dihydroxybutanedioate 
194 2933 19 90 18048-64-1 2-(3,4-dimethylphenyl)-5- methyl-2,4-dihydro-3H-pyrazol-3-one 
477 2933 19 90 1035675-24-1 3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H -pyrazole-1-
carboximidamide 
310 2933 19 90 1028026-83-6 5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzy l]-1,2-dihydro-
3H-pyrazol-3-one 
585 2933 19 90 473921-12-9 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl] oxy}benzene-1,3-
dicarbonitrile 
89 2933 29 90 65902-59-2 2-bromo-4-nitro-1H-imidazo le 
90 2933 29 90 57531-37-0 2-chloro-4-nitro-1H-imidaz ole 
24 2933 29 90 1000164-35-1 3-(1,1-dimethylethyl)-N- [(9H-fluoren-9-ylmethoxy)carbonyl]-1-Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 17                  WT/Let/1268 ID CN code CAS RN Name 
(triphenylmethyl)-L-histidyl-2-methylalanyl-L- α-glutamylglycine 
488 2933 29 90 152074-97-0 L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-
histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-as paraginyl-L-
isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-t hreonine 
489 2933 29 90 781666-30-6 L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-
histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-as paraginyl-L-
isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-t hreonine 
tetraacetate 
176 2933 29 90 451470-33-0 methyl 3'-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)bi phenyl-3-
carboxylate 
348 2933 39 99 925978-49-0 (+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-
azabicyclo[3.2.1]octane 
325 2933 39 99 876170-44-4 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyc lo[3.2.0]heptane 
benzenesulfonate 
1 2933 39 99 741705-70-4 (2R)-phenyl[(2R)-piperidin-2 -yl]ethanoic acid hydrochloride 
162 2933 39 99 414910-13-7 (2S)-hydroxy(phenyl)ethanoic acid -- (2R)-2-(4-fluor o-2-
methylphenyl)piperidin-4-one (1:1) 
314 2933 39 99 0-00-0 (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrr ole 4-
methylbenzenesulfonate 
315 2933 39 99 370882-57-8 (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrr ole 
dihydrochloride 
121 2933 39 99 334618-23-4 (3R)-piperidin-3-amine di hydrochloride 
579 2933 39 99 1062580-52-2 (3R,4R)-1-benzyl-N,4-dime thylpiperidin-3-amine dihydrochloride 
578 2933 39 99 27262-47-1 (S)-1-butyl-N-(2,6-dimeth ylphenyl)piperidine-2-carboxamide 
183 2933 39 99 105812-81-5 [(3S,4R)-4-(4-fluoropheny l)-1-methylpiperidin-3-yl]methanol 
324 2933 39 99 876068-51-8 [(3S,4S)-4-amino-1-(5,6- dichloropyridin-3-yl)pyrrolidin-3-yl]methanol 
408 2933 39 99 871022-14-9 1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benz imidazol-1-
yl]carbonyl}amino)methyl]piperidin-1-
yl}methyl)cyclobutanecarboxylic acid 
549 2933 39 99 5421-92-1 1-(pyridin-4-yl)pyridinium  chloride hydrochloride 
541 2933 39 99 272776-12-2  1,1'-binaphthalene-2,2'-diol --5-methoxy-2-{(S)-[(4 -methoxy-3,5-
dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidaz ole(1:1) 
409 2933 39 99 871022-19-4 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin -1-
yl)methyl]cyclobutanecarboxylicacid 
414 2933 39 99 3613-73-8 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3, 4,5-tetrahydro-1H-
pyrido[4,3-b]indole 
535 2933 39 99 179687-79-7 2-[(2-chloro-4-nitrophen oxy)methyl]pyridine 
201 2933 39 99 122321-04-4 2-[methyl(pyridin-2-yl)a mino]ethanol 
311 2933 39 99 945405-37-8 2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2, 3-
dihydroxybutanedioate 
155 2933 39 99 936637-40-0 3,3'-piperidine-1,4-diyl dipropan-1-ol 4-methylbenzenesulfonate 
40 2933 39 99 88150-62-3 3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-diox o-1,3-dihydro-
2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydr opyridine-3,5-
dicarboxylate 
404 2933 39 99 84100-54-9 4-(ethylamino)piperidine- 4-carboxamide 
157 2933 39 99 873546-30-6 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]b is(N'-
hydroxybenzenecarboximidamide) 
158 2933 39 99 873546-74-8 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]b is[N'-
(acetyloxy)benzenecarboximidamide] 
159 2933 39 99 873546-38-4 4,4'-[piperidine-1,4-diylbis(propane-3,1-
diyloxy)]dibenzenecarboximidamide trihydrochloride pentahydrate 
156 2933 39 99 873546-80-6 4,4'-[piperidine-1,4-diy lbis(propane-3,1-diyloxy)]dibenzonitrile 
316 2933 39 99 78750-61-5 4-[(3-nitropyridin-2-yl)a mino]phenol 
87 2933 39 99 866109-93-5 4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}ph enol 4-
methylbenzenesulfonate 
472 2933 39 99 927889-51-8 4-bromo-2,6-diethylpyrid ine 4-methylbenzenesulfonate 
272 2933 39 99 691882-47-0 4-hydroxybenzoic acid -- (2S,4E)-N-methyl-5-[5-(pro pan-2-
yloxy)pyridin-3-yl]pent-4-en-2-amine (1:1) 
323 2933 39 99 876068-46-1 5,6-dichloro-N-(2,2-dime thoxyethyl)pyridin-3-amine 
220 2933 39 99 1072-98-6 5-chloropyridin-2-amine  
85 2933 39 99 298692-34-9 6-(chloroacetyl)pyridine- 2-carboxylic acid 
349 2933 39 99 550349-58-1 7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl- 4-oxo-4,5-
dihydro-3H-pyridazino[4,5-b]indole-1-carboxamide 
160 2933 39 99 414909-98-1 benzyl 2-(4-fluoro-2-met hylphenyl)-4-oxo-3,4-dihydropyridine-1(2H)-Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 18                  WT/Let/1268 ID CN code CAS RN Name 
carboxylate 
164 2933 39 99 56880-11-6 ethyl [(3-endo)-8-methyl- 8-azabicyclo[3.2.1]oct-3-yl)acetate 
273 2933 39 99 548797-97-3 N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]am ino}-2-hydroxy-
2-methylpropyl]oxy}-4-hydroxyphenyl)acetamide 
352 2933 39 99 0-00-0 N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2 ,6-dichloro-3-
(trifluoromethyl)benzamide hydrochloride 
289 2933 39 99 329003-65-8 sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3 -
yl)ethyl]phosphonate hemipentahydrate 
58 2933 49 10 417716-92-8 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy} -7-
methoxyquinoline-6-carboxamide methanesulfonate 
584 2933 49 90 503291-53-0 2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetra zol-5-
yl)phenoxy]decahydro-3-isoquinolinecarboxylate 4-
methylbenzenesulfonate 
539 2933 49 90 103733-32-0  benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoqui noline-3-
carboxylate hydrochloride 
581 2933 49 90 503293-98-9 (3S,4aS,6S,8aR)-6-hydroxy-2-
(methoxycarbonyl)decahydroisoquinoline-3-carboxylic  acid 
583 2933 49 90 503290-66-2 (3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-yl)phen oxy]decahydro-
3-isoquinolinecarboxylic acid hydrochloride 
580 2933 49 90 134388-95-7 (3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoqu inoline-3-
carboxylic acid --(1R)-1-phenylethanamine (1:1) 
328 2933 49 90 868210-14-4 4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-met hyl-3,4-
dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dime thylbutanoic 
acid 
545 2933 49 90 00-00-0 methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)et henyl]phenyl}-3-
({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)pro pyl]benzoate 
hydrochloride 
534 2933 49 90  848133-76-6 N-(4-chloro-3-cyano-7-e thoxyquinolin-6-yl)acetamide 
479 2933 59 95 869490-23-3 (3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimid in-2-yl)piperazin-
1-yl]pyrrolidin-2-yl}methanone 
421 2933 59 95 941685-40-1 (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethox y]methyl}-7H-
pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propa nenitrile 
416 2933 59 95 941678-49-5 (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin- 4-yl)-1H-
pyrazol-1-yl]propanenitrile 
420 2933 59 95 941685-41-2 (3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)etho xy]methyl}-7H-
pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propa nenitrile 
394 2933 59 95 957187-34-7 [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4 .5]dec-9-
yl]acetic acid 
190 2933 59 95 356058-42-9 {2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahy dro-1H-
cyclopenta[d]pyrimidin-1-yl}acetic acid 
395 2933 59 95 0-00-0 2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic ac id -- ethyl [(8R)-
8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]de c-9-yl]acetate 
(1:1) 
407 2933 59 95 90213-66-4 2,4-dichloro-7H-pyrrolo[2 ,3-d]pyrimidine 
197 2933 59 95 3934-20-1 2,4-dichloropyrimidine 
189 2933 59 95 451487-18-6 2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-
cyclopenta[d]pyrimidin-4-one 
120 2933 59 95 865758-96-9 2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidi n-1(2H)-
yl)methyl]benzonitrile 
340 2933 59 95 934815-71-1 2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-meth oxypyrimidin-4-
yl)phenyl]-2-methylpropanoic acid phosphate 
278 2933 59 95 722543-31-9 2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxo ethyl}-1H-
pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino }ethyl 
dihydrogen phosphate 
361 2933 59 95 1032066-96-8 2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-
[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-1 ,9-dihydro-6H-
purin-6-one -- methanesulfonate (2:1) 
406 2933 59 95 540737-29-9 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimi din-4-
yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydr oxypropane-1,2,3-
tricarboxylate 
400 2933 59 95 1137917-12-4 3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-h ydroxypropan-2-
yl]oxy}benzoic acid -- 1,4-diazabicyclo[2.2.2]octan e (2:1) 
422 2933 59 95 941685-39-8 3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]me thyl}-7H-
pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propa nenitrile 
419 2933 59 95 941685-27-4 4-(1H-pyrazol-4-yl)-7-{[ 2-(trimethylsilyl)ethoxy]methyl}-7H-Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 19                  WT/Let/1268 ID CN code CAS RN Name 
pyrrolo[2,3-d]pyrimidine 
365 2933 59 95 1780-26-3 4,6-dichloro-2-methylpyrim idine 
567 2933 59 95 145783-14-8 4,6-dichloro-5-nitro-2-( propylsulfanyl)pyrimidine 
423 2933 59 95 3680-69-1 4-chloro-7H-pyrrolo[2,3-d] pyrimidine 
215 2933 59 95 61379-64-4 4-cyclopentylpiperazin-1- amine 
219 2933 59 95 55112-42-0 4-methylpiperazine-1-carb onyl chloride hydrochloride 
338 2933 59 95 0-00-0 5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpipe razin-1-
yl)[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile - - (2E)-but-2-
enedioate (2:1) hydrate 
471 2933 59 95 55293-96-4 5,7-dimethyl[1,2,4]triazo lo[1,5-a]pyrimidine-2-carbaldehyde 
288 2933 59 95 179688-01-8 7-(benzyloxy)-6-methoxyq uinazolin-4(3H)-one 
198 2933 59 95 444731-74-2 N-(2-chloropyrimidin-4-y l)-2,3-dimethyl-2H-indazol-6-amine 
355 2933 59 95 0-00-0 N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyr idin-2-
yl)pyrimidine-5-carboxamide 
484 2933 79 00 586414-48-4 (-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl -2-oxopyridin-
1(2H)-yl}-N,4-dimethylbenzamide 
486 2933 79 00 425663-71-4 (1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benza zepin-2-one 
hydrochloride 
34 2933 79 00 813452-14-1 (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6 ,7,11b-
hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-
(fluoromethyl)pyrrolidin-2-one dihydrochloride 
77 2933 79 00 5162-90-3 3-(2-oxo-1,2-dihydroquinoli n-4-yl)alanine 
384 2933 79 00 536760-29-9 3-chloro-1-(4-nitropheny l)-5,6-dihydropyridin-2(1H)-one 
78 2933 79 00 4876-10-2 4-(bromomethyl)quinolin-2(1 H)-one 
69 2933 79 00 5057-12-5 4,6,7,8-tetrahydroquinoline -2,5(1H,3H)-dione 
72 2933 79 00 54197-66-9 6-hydroxy-3,4-dihydroquino lin-2(1H)-one 
75 2933 79 00 22246-18-0 7-hydroxy-3,4-dihydroquino lin-2(1H)-one 
380 2933 79 00 536759-91-8 ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4 ,5,6,7-tetrahydro-
1H-pyrazolo[3,4-c]pyridine-3-carboxylate 
382 2933 79 00 503614-91-3 ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidi n-1-yl)phenyl]-
4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-car boxylate 
485 2933 79 00 586379-61-5 methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl) -4-
methylbenzoate 
368 2933 99 80 709031-45-8 (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide 
methanesulfonate 
376 2933 99 80 649735-46-6 (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-
methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan- 2-ol 
276 2933 99 80 51077-14-6 (2S)-1-(tert-butoxycarbon yl)azetidine-2-carboxylic acid 
277 2933 99 80 631916-97-7 (2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1- {(2R)-2-[3-
chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl }azetidine-2-
carboxamide -- benzenesulphonic acid (1:1) 
564 2933 99 80 80875-98-5 (2S,3aS,7aS)-octahydro-1H -indole-2-carboxylic acid 
313 2933 99 80 948846-40-0 (2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic aci d -- ethyl 
(3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carbox ylate (1:1) 
302 2933 99 80 1000164-36-2 (5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-( 3-amino-3-
oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis {4-[(tert-
butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarb onyl)-1H-indol-
3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-f luoren-9-yl)-
8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-
3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-( propan-2-yl)-2-
oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaaza dotetracontan-42-
oic acid 
529 2933 99 80 22162-51-2 1-(2-nitrobenzyl)-1H-pyrr ole-2-carbaldehyde 
410 2933 99 80 35681-40-4 1-(propan-2-yl)-1,3-dihyd ro-2H-benzimidazol-2-one 
522 2933 99 80 166170-15-6 1-(tert-butoxycarbonyl)- 2-methyl-D-proline 
322 2933 99 80 796967-16-3 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5 -
methylphenyl)urea 
321 2933 99 80 0-00-0 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5 -
methylphenyl)urea hydrochloride 
196 2933 99 80 444731-72-0 2,3-dimethyl-2H-indazol- 6-amine 
415 2933 99 80 19686-05-6 2,8-dimethyl-2,3,4,5-tetr ahydro-1H-pyrido[4,3-b]indole 
524 2933 99 80 912444-00-9 2-[(2R)-2-methylpyrrolidi n-2-yl]-1H-benzimidazole-4-carboxamide 
523 2933 99 80 912445-36-4 2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4 -carboxamide 
dihydrochloride Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 20                  WT/Let/1268 ID CN code CAS RN Name 
481 2933 99 80 163457-23-6 3,3-difluoropyrrolidine hydrochloride 
65 2933 99 80 239463-85-5 3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-ind ol-1-yl}propyl 
benzoate (2R,3R)-2,3-dihydroxybutanedioate 
150 2933 99 80 55321-99-8 3-oxo-3,4-dihydropyrazine -2-carboxamide 
375 2933 99 80 952490-01-6 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpy rrolo[2,1-
f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate 
274 2933 99 80 942436-93-3 4-amino-8-(2,5-dimethoxy phenyl)-N-propylcinnoline-3-carboxamide 
275 2933 99 80 942437-37-8 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnol ine-3-
carboxamide 
285 2933 99 80 288385-88-6 4-fluoro-2-methyl-1H-ind ol-5-ol 
582 2933 99 80 503293-47-8 5-(2-chloro-6-fluorophen yl)-2H-tetrazole 
71 2933 99 80 73963-42-5 5-(4-chlorobutyl)-1-cycloh exyl-1H-tetrazole 
271 2933 99 80 606143-52-6 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hyd roxyethoxy)-1-
methyl-1H-benzimidazole-6-carboxamide 
347 2933 99 80 0-00-0 5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-in dole-2-
carboxamide 
373 2933 99 80 872206-47-8 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]tria zin-6-yl 2,2-
dimethylpropanoate 
151 2933 99 80 259793-88-9 6-bromo-3-oxo-3,4-dihydr opyrazine-2-carboxamide 
562 2933 99 80 1137606-74-6 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile - - N-
cyclohexylcyclohexanamine (1:1) 
482 2933 99 80 261953-36-0 6-iodo-1H-indazole 
73 2933 99 80 80076-47-7 8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrid o[3,2,1-
ij]quinoline-2-carboxylic acid 
188 2933 99 80 52602-39-8 9H-carbazol-4-ol 
235 2933 99 80 145641-35-6 benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylat e 
hydrochloride 
540 2933 99 80 87269-87-2 benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2 -carboxylate 
hydrochloride  
21 2933 99 80 1012065-72-3 ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4 H-pyrido[2,1-
a]isoquinoline-3-carboxylate 
563 2933 99 80 131707-24-9 ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl )methyl]-1H-
indole-3-carboxylate 
124 2933 99 80 105152-95-2 ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophe nyl)-6-fluoro-4-
oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate 
117 2933 99 80 139481-44-0 methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1 H-
benzimidazole-7-carboxylate 
393 2933 99 80 0-00-0 methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyri dine-3-
carboxylate 
555 2933 99 80 21688-11-9 N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl -S-benzyl-L-
cysteinyl-L-prolyl-L-leucylglycinamide 
370 2933 99 80 361440-67-7 tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1. 0]hexane-2-
carboxylate 
371 2933 99 80 709031-38-9 tert-butyl (2S)-2-carbam oyl-2,3-dihydro-1H-pyrrole-1-carboxylate 
366 2933 99 80 709031-43-6 tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo [3.1.0]hex-2-yl]-1-
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethy l]carbamate 
588 2933 49 90 936359-25-0 methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vin yl)phenyl)-3-(((1-
(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)b enzoate  
341 2934 10 00 110130-88-6 (2Z)-[(acetyloxy)imino]( 2-amino-1,3-thiazol-4-yl)ethanoic acid 
547 2934 10 00 68672-66-2 (2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy ]imino}[2-
(tritylamino)-1,3-thiazol-4-yl]ethanoic acid 
202 2934 10 00 291536-35-1 (5Z)-5-(4-fluorobenzylid ene)-1,3-thiazolidine-2,4-dione 
362 2934 10 00 302964-24-5 2-amino-N-(2-chloro-6-me thylphenyl)-1,3-thiazole-5-carboxamide 
339 2934 10 00 866920-24-3 3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phen yl]-1,3-thiazol-5-
yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one 
353 2934 10 00 752253-39-7 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyc lopropyl-1-(3-
fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn- 1-yl)-1,3-
thiazol-2-amine 
57 2934 10 00 914361-45-8 L-lysine -- {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazo l-2-yl]-2-(2,4-
difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl ]oxy}methyl 
dihydrogen phosphate -- ethanol (1:1:1) 
363 2934 10 00 302964-08-5 N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpy rimidin-4-
yl)amino]-1,3-thiazole-5-carboxamide 
107 2934 10 00 127660-04-2 sodium (2Z)-(2-amino-1,3 -thiazol-4-yl)(hydroxyimino)ethanoate Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 21                  WT/Let/1268 ID CN code CAS RN Name 
135 2934 99 90 17381-54-3 (1-benzothiophen-5-yl)ace tic acid 
60 2934 99 90 630100-90-2 (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-( 1-
carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydr oxy-2,6-dimethyl-
11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}- 3,5-dideoxy-1-
[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol 
283 2934 99 90 220099-91-2 (2R)-3'H-spiro[4-azabicyc lo[2.2.2]octane-2,2'-furo[2,3-b]pyridine] 
282 2934 99 90 220100-81-2 (2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2 ,3-b]pyridine] 
(S,S)-2,3-dihydroxybutanedioate 
29 2934 99 90 161599-46-8 (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)- yl)-2-
fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate 
30 2934 99 90 690270-65-6 (2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azid o-2-{[(2-
methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl  bis(2-
methylpropanoate) hydrochloride 
392 2934 99 90 265121-04-8 (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)pheny l]ethoxy}-3-(2-
fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihyd ro-1H-1,2,4-
triazol-1-yl)phosphonic acid -- 1-deoxy-1-(methylam ino)-D-glucitol 
(1:2) 
126 2934 99 90 163680-80-6 (3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-met hyl-7-oxo-2,3-
dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carbox ylic acid 
544 2934 99 90 132335-46-7 (3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophe n-2-yl)propan-1-
amine 
345 2934 99 90 133413-70-4 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,1 6,22,24-
hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,1 3,19-tetraoxa-
4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17, 20,23-octone 
169 2934 99 90 503068-36-8 (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)- 5-(2,2-
dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2- one 
166 2934 99 90 452339-73-0 (5R)-5-(2,2-dimethyl-4H-1 ,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one 
470 2934 99 90 877130-28-4 (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)eth yl]-3-[(5,7-
dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl ]-4-hydroxy-5,6-
dihydro-2H-pyran-2-one 
543 2934 99 90 132335-44-5 (S)-3-(dimethylamino)-1- (thiophen-2-yl)propan-1-ol  
31 2934 99 90 812647-80-6 {(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimid in-1(2H)-
yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-y l}methyl 3-
chlorobenzoate 
551 2934 99 90 00-00-0 1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl }-1,2,3,6-
tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol -2-one 
418 2934 99 90 1029716-44-6 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-diox aborolan-2-yl)-1H-
pyrazole 
358 2934 99 90 165172-60-1 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]- 5-
methylpyrimidine-2,4(1H,3H)-dione -- 1-methylpyrrol idin-2-one (1:1) 
139 2934 99 90 519187-97-4 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidin ol -- (2Z)-2-
butenedioate (1:1) 
49 2934 99 90 127000-90-2 1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2- yl]methyl}-1H-
1,2,4-triazole 
332 2934 99 90 710281-33-7 2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-ox azol-4-
yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic a cid 
136 2934 99 90 96803-30-4 2-(1-benzothiophen-5-yl)e thanol 
59 2934 99 90 913695-00-8 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5- dimethylpyridin-
2-yl}methyl)sulfinyl]-1Hbenzimidazole, sodium salt (1:1) 
286 2934 99 90 376608-74-1 2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-
(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethylt etrahydro-3aH-
cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol 
55 2934 99 90 474554-48-8 2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-
yl)phenyl]ethanone 
148 2934 99 90 530141-72-1 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl} -2-[(3-hydroxy-
1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid 
138 2934 99 90 519188-55-7 3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazet idin-1-yl)propan-
1-one 
137 2934 99 90 519188-42-2 3-[2-(1-benzothiophen-5- yl)ethoxy]propionic acid 
566 2934 99 90 753015-42-8 3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydr o-2H-pyran-4-
yloxy)pyridine 
557 2934 99 90 26638-53-9 3-chloro-6-methyldibenzo[ c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide 
153 2934 99 90 499785-81-8 3-oxo-4-(2,3,5-tri-O-acetyl- β-D-ribofuranosyl)-3,4-dihydropyrazine-2-
carboxamide 
154 2934 99 90 356782-84-8 3-oxo-4-( β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide  Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 22                  WT/Let/1268 ID CN code CAS RN Name 
211 2934 99 90 6504-57-0 4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-me thylmorpholin-
4-ium methyl sulfate 
329 2934 99 90 871484-32-1 4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy] -5-(propan-2-
yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy -2-
(hydroxymethyl)propan-2-yl]butanamide 
575 2934 99 90 166964-09-6 4-chloro-3-methyl-1,2-ox azol-5-amine 
93 2934 99 90 655233-39-3 4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydro furan-2-yl]-5-
thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hyd rochloride 
542 2920 90 85  89729-09-9 5,7-dioxa-6-thiaspiro[2. 5]octane-6-oxide  
172 2934 99 90 388082-75-5 5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]a mino]-6-
quinazolinyl]-2-furancarboxaldehyde-- 4-methylbenze nesulfonate (1:1) 
134 2934 99 90 4923-87-9 5-bromo-1-benzothiophene 
146 2934 99 90 947408-95-9 6-(bromomethyl)-2-triphe nylmethyl-1,2-benzisoxazol-3(2H)-one 
145 2934 99 90 947408-94-8 6-methyl-2-trityl-1,2-be nzoxazol-3(2H)-one 
110 2934 99 90 67978-05-6 diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphe nyl)-7-oxo-
4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-e noate 
357 2934 99 90 1001859-46-6 DNA (synthetic plasmid vector pCOR human interferon b eta signal 
peptide fusion protein with 21-154-human acidic fib roblast growth 
factor-specifying) 
326 2934 99 90 665058-78-6 DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G- sp-A-sp-C-
G-sp-T-sp-T-sp-T-sp-T-sp-Gsp-T-sp-C-G-sp-T-sp-T) 
401 2934 99 90 923591-06-4 methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9, 12-trioxo-
6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H- 2,23:5,8-
dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosi ne-7(3H)-
carboxylate 
577 2934 99 90 59337-92-7 methyl 3-(chlorosulfonyl) thiophene-2-carboxylate 
147 2934 99 90 947409-01-0 methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2 -[(2-
triphenylmethyl-1,2-benzisoxazol-3(2H)-on-6-yl)meth oxy] 
phenyl]propionate 
212 2934 99 90 85006-31-1 methyl 3-amino-4-methylth iophene-2-carboxylate 
280 2934 99 90 893428-72-3 N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-
piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)ox y]-4-
quinazolinamine -- (2E)-2-butenedioate (1:2) 
18 2934 99 90 390800-88-1 N,N',N''-(boroxin-2,4,6-triyltris{[(1S)-3-methylbut ane-1,1-
diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tr ipyrazine-2-
carboxamide 
99 2934 99 90 112913-94-7 N-{[4-(4-fluorobenzyl)mor pholin-2-yl]methyl}acetamide 
412 2934 99 90 120788-03-6 S-[(1R,3S)-1-oxidotetrahy drothiophen-3-yl] ethanethioate 
402 2935 00 90 1198178-65-2 (1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-
ethylcyclopropanaminium 4-methylbenzenesulfonate 
556 2935 00 90 39570-96-2 (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydraz inyl-3-methyl-1-
oxopentan-2-yl]amino}-3-(4-hydroxyphenyl)-1-oxoprop an-2-yl]-2-
{[(4-methylphenyl)sulfonyl]amino}propanamide 
79 2935 00 90 24310-36-9 1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H- 1-benzazepin-5-
one 
346 2935 00 90 0-00-0 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin- 2-yl]ethyl}-
1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E )-but-2-enedioate] 
hydrate 
281 2935 00 90 941690-55-7 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-
phenylpropyl]quinoline-4-carboxamide 
199 2935 00 90 6973-09-7 5-amino-2-methylbenzenesul fonamide 
82 2935 00 90 193686-76-9 7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetra hydro-5H-1-
benzazepin-5-one 
130 2935 00 90 123664-84-6 N-(5-methoxy-2-phenoxyph enyl)methanesulfonamide 
133 2935 00 90 149457-03-4 N-[4-(N-formylglycyl)-5-hydroxy-2-
phenoxyphenyl]methanesulfonamide 
132 2935 00 90 149456-98-4 N-[4-(N-formylglycyl)-5-methoxy-2-
phenoxyphenyl]methanesulfonamide 
319 2935 00 90 141450-48-8 N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-
methoxybenzenesulfonamide hydrochloride 
391 2935 00 90 289042-10-0 N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl )-6-(propan-2-
yl)pyrimidin-2-yl}-N-methylmethanesulfonamide 
187 2939 99 00 7689-03-4 (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizi no[1,2-
b]quinoline-3,14(4H,12H)-dione 
239 2939 99 00 477-29-2 colchicoside Schedule XIV – Norway – Pharmaceuticals – Annex III   Page 23                  WT/Let/1268 ID CN code CAS RN Name 
173 2940 00 00 604-69-3 1,2,3,4,6-penta-O-acetyl- β-D-glucopyranose 
333 2940 00 00 647834-15-9 2-(4-methoxybenzyl)thiop hen-3-yl β-D-glucopyranoside 
127 2941 90 00 76610-92-9 (6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbo nyl]-D-
threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulf anyl]methyl}-8-
oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyli c acid 
570 3907 20 99 913976-27-9 poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester with 21N6, 
21’N6-[[(N2, N6-dicarboxy-L-lysyl- β-alanyl)imino]bis(1-oxo-2, 1-
ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L -alanyl-L-
cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-i soleucyl-L-
threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cyst einyl-L-
glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglyc yl-L-lysinamide] 
cyclic (6 →15), (6’ →15’) bis(disulfide) 
 Schedule XIV – Norway – Pharmaceuticals – Annex IV  Page 24                  WT/Let/1268 ANNEX IV 
List of pharmaceutical intermediates, i.e. compounds  used for the manufacture of finished pharmaceutica l products, 
to be withdrawn from the list of products receiving  duty-free treatment included in Annex 6 to Annex I  to Regulation 
(EEC) No 2658/87 due to their transfer to the list of  products receiving duty-free treatment included in  Annex 3  to 
Annex I to Regulation (EEC) No 2658/87 
 
CN code CAS RN Name 
2915 39 00  
 
2937 29 00  7753-60-8 17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21- yl acetate 
 
see anecortave (INN) 
2920 90 85 163133-43-5 4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)prop anoate 
 
see naproxcinod (INN) 
2924 29 98 194085-75-1 2-(2-chlorophenyl)-2-hydroxyethyl carbamate 
 
see carisbamate (INN) 
2933 39 99 103129-82-4 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chl orophenyl)-6-methyl-1,4-
dihydropyridine-3,5-dicarboxylate 
 
see levamlodipine (INN) 
2933 39 99 319460-85-0 N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol -6-yl]sulfanyl}benzamide 
 
see axitinib (INN) 
2934 10 00 302962-49-8 N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethy l)piperazin-1-yl]-2-
methylpyrimidin-4-yl}amino)thiazole-5-carboxamide 
 
see dasatinib (INN) 
2934 99 90 143491-57-0 (2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-ox athiolan-5-yl]pyrimidin-
2(1H)-one 
 
see emtricitabine(INN) 
2934 99 90 98819-76-2 (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholin e 
 
see esreboxetine (INN) 
2934 99 90 475479-34-6 (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazo l-4-yl)ethoxy]-1-
benzothiophen-7-yl}propanoic acid 
 
see aleglitazar (INN) 
2934 99 90 377727-87-2 2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]pipe razin-1-yl}ethyl)-7H-
pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-am ine 
 
see preladenant (INN) 
2934 99 90 189003-92-7 2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-yl piperazin-1-yl)ethyl]quinolin-
1(2H)-yl}acetamide 
 
see trelanserin (INN) 
2934 99 90 134379-77-4 4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-d ihydrofuran-2-yl]pyrimidin-
2(1H)-one 
 
see dexelvucitabine (INN) 
2934 99 90 518048-05-0 potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl- 2-[1-methyl-1-(5-methyl-
1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dih ydropyrimidine-5-olate 
 
see raltegravir (INN) 
2935 00 90 170569-88-7 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1- yl]benzene-1-sulfonamide 
 
see mavacoxib (INN) 
2935 00 90 186497-07-4 N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxad iazol-2-yl)phenyl]pyridine-
3-sulfonamide 
 
see zibotentan (INN) 
 
 
__________